Condensed Consolidated Statements of Cash Flows (USD $)	9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011
Operating activities
Net loss	$ (3,650,367)	$ (4,546,766)
Adjustments to reconcile net loss to net cash used in operating activities:
Realization of cumulative translation adjustment	(1,227,656)
Bad debt recovery		(8,168)
Change in fair value of derivative instruments	(341,118)	(6,075,555)
Depreciation and amortization expense	234,811	348,813
Gain of the disposal of property and equipment	(66,626)
Share-based compensation expense	1,499,910	1,881,416
Deferred income taxes	188,610
Non-cash interest expense	81,252
Changes in operating assets and liabilities:
Accounts receivable	2,818,201	1,080,032
Unbilled accounts receivable	(661,103)	1,357,711
Prepaid expenses and other current assets	557,683	1,439,312
Accounts payable	400,764	(2,684,507)
Accrued expenses and other liabilities	(12,225)	204,291
Net cash used in operating activities	(177,864)	(7,003,421)
Investing activities
Purchases of property and equipment		(71,439)
Proceeds from the sale of property and equipment	67,400
Net cash provided by (used in) investing activities	67,400	(71,439)
Financing activities
Proceeds from issuance of long term debt and warrants	2,500,000
Net proceeds from (repayment of) revolving credit agreement	1,208,370
Deferred financing costs	(216,460)
Change in restricted cash requirements	100,000
Proceeds from issuance of common stock and warrants	38,984	5,814,639
Other	(32,960)	(64,362)
Net cash provided by financing activities	3,597,934	5,750,277
Effects of exchange rates on cash	2,087	(54,668)
Increase (decrease) in cash and cash equivalents	3,489,557	(1,379,251)
Cash and cash equivalents, at beginning of period	11,236,771	11,785,327
Cash and cash equivalents, at end of period	14,726,328	10,406,076
Supplemental disclosure of cash flow information
Cash paid for interest	145,658	40,540
Noncash financing activity
Value of warrants issued to lender in connection with loan	$ 69,876